Pfizer to seek FDA nod for vaccine for children as young as six months, and latest studies find omicron may not protect against future infection

Federal regulators are expected to be asked as soon as Tuesday to authorize Pfizer’s COVID-19 vaccine for children as young as 6 months old, and the first shots could come by the end of February, according to news reports Monday night.